Enterprise Value
190.1M
Cash
205.9M
Avg Qtr Burn
-9.227M
Short % of Float
17.69%
Insider Ownership
13.11%
Institutional Own.
65.29%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ALTO-300 Details Major depressive disorder | Phase 2b Data readout | |
ALTO-100 Details Major depressive disorder | Phase 2b Data readout | |
ALTO-101 Details Cognitive Impairment Associated with Schizophrenia | Phase 2 Data readout | |
ALTO-203 Details Major depressive disorder | Phase 2 Data readout |